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Abstract – A mixture of an azodicarboxylate and triphenylphosphine in 
dichloromethane reacted with aryl isoselenocyanates (1) at room 
temperature to give 4,5-dihydro-5-selenoxo-1H-1,2,4-triazole-1-
carboxylates (4a-f) in a one-pot reaction in good to excellent yields. The 
isoselenocyanates (1) have been prepared conveniently from formamides 
by treatment with elemental selenium and phosgene according to Barton’s 
procedure. 
 
INTRODUCTION 
 
Organoselenium compounds have continued to attract the attention of organic and medicinal 
chemists owing to their unique biological and pharmaceutical activities.3 It has been shown that 
the deficiency of selenium in human and animal organisms constitutes the basis of various 
chronic diseases.4,5 Despite the high toxicity of many selenium compounds, organic derivatives 
of selenium have been synthesized as antitumor,6,7 anticancer,8-10 anticarcinogenic,11 and other 
medicinal preparations,12 as well as biologically active substances exhibiting antiviral,13 
antimicrobial,14 antihypertensive,15 and fungicidal activities.16 
 
The main drawbacks of some syntheses are the toxicity of commonly used selenium reagents 
 and the instability of some intermediates. With the aim of developing syntheses of new 
selenaheterocycles and heterocyclic selones by using less-toxic, conveniently accessible and 
safely usable selenium reagents, we have investigated reactions with various 
isoselenocyanates.17-29 They are materials of choice30 for the synthesis of numerous Se-
containing heterocycles,31 since they are easy to prepare and can be stored. We have already 
shown that aryl isoselenocyanates (1) are very useful precursors for the introduction of 
selenium into four, five, six and seven membered heterocycles like selenazetidines,25 
selenazolones,29 selenazolidines,26 selenazines,26 perhydroselenazin-4- and -5-ones,29 and 
selenazepanes.28 The general concept of these reactions is shown in Scheme 1: nucleophilic 
addition of a suitably substituted compound (2) to the isoselenocyanate (1) to give a zwitterion 
(3), which undergoes ring closure to yield selenaheterocycles (4) (see refs.20-23,26). An 
alternative cyclization via the nitrogen atom leads to N-heterocyclic selones (5) (see refs.24,27).  
 
Scheme 1 
 
 
As a continuation of our studies, we investigated the reaction of isoselenocyanates with diethyl 
azodicarboxylate (6) and triphenylphosphine under Mitsunobu conditions. This reaction was 
expected to give either 1,3,4-selenatriazole or 1,2,4-triazoleselone derivatives.32 To the best of 
our knowledge, only a few 1,2,4-triazoleselones34 and their isomeric 1,2,4-triazoleselenols35 
have been described. The main synthesis starts from a triazole, which is a good precursor for 
the preparation of the carbene 1,2,4-triazol-3-ylidene.36 The latter reacts with elemental 
selenium by forming the carbon-selenium double bond.37  
 
Isoselenocyanates have already been used for the synthesis of mesoionic 1,2,4-triazolo-3-
selones.38 This preparation, published in 1976 by Egorochkin39 and in 2000 by Miller,40 was 
 carried out by reacting 1,1-diacylhydrazines with an isoselenocyanate in the presence of 
triethylamine in boiling THF. 
 
RESULTS AND DISCUSSION 
 
Equimolar amounts of diethyl azodicarboxylate (6, DEAD) and triphenylphosphine (Ph3P) were 
dissolved in dichloromethane, and the pale yellow solution was stirred for 30 min at 0°C. Then, 
an equimolar amount of an aryl isoselenocyanate (1), which had been prepared conveniently by  
a slightly modified Barton procedure41 from the corresponding N-arylformamide by treatment 
with phosgene and elemental selenium, was added and the mixture stirred at room temperature 
overnight. After evaporation of the solvent, the crude products were obtained as mixtures with 
triphenylphospine oxide (Ph3PO; TLC detection), and separation by column chromatography 
(SiO2, hexane/ethyl acetate) was necessary to get the ethyl 5-selenoxo-1H-1,2,4-triazole-1-
carboxylates (7a-e) (Scheme 2, Table 1). It has to be noted that this purification process is not 
easy. A side-product always polluted the final product, and only trituration with diethyl ether or 
dichloromethane and recrystallization from ethyl acetate led to pure 7.42 
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The structure of the products (7) was determined on the basis of their elemental analyses and 
spectroscopic data. The IR spectra (KBr) show two strong bands at 1765-1773 and 1619-1625 
cm-1 for the carboxylate and the C=N group, respectively. In the 13C-NMR spectra (CDCl3), 
indicative absorptions for CO2Et, C(5)=Se, and C(3) appear at ca. 167, 156, and 148 ppm, 
respectively. The ESI-MS spectra show the characteristic sets of the selenium isotope peaks for 
[M+Na]+. Finally, the structure of 7e was established by an X-Ray crystal-structure 
determination (Figure 1).  
 
The five-membered ring of 7e is planar and the attached atoms Se(1), C(6), O(3), and C(5) 
 deviate only slightly from the ring plane (maximum derivation is 0.148(2) Å for C(6)). Whereas 
the ethoxy group at C(3) is co-planar with the heterocycle and the ester group, with the 
exception of the terminal CH3 group, is only slightly twisted out of the heterocyclic ring plane 
(angle between the planes is 8.1(1)°), the benzene ring at N(2) is oriented almost orthogonal to 
the plane of the heterocyclic ring (angle between the planes is 74.2(1)°). 
 
Table 1. Preparation of Triazole Derivatives (7) from Isoselenocyanates (1)  
Entry Ar 4 Yield (%) 
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Figure 1. ORTEP plot45 of the molecular structure of 7e (arbitrary numbering of atoms; 50% 
probability ellipsoids). 
 
Scheme 3 
 
 A likely reaction mechanism for the formation of 7 is proposed in Scheme 3. The addition of 
Ph3P onto the azodicarboxylate (6) generates the zwitterion (8), which, as a nucleophile, 
attacks the isoselenocyanate (1) to give 9. Ring closure by nucleophilic addition of the N-atom 
at the ester group leads to 10, and elimination of Ph3PO via the intermediate (11) yields the 
product (7). 
 
The use of the system diethyl azodicarboxylate (oxidant)/Ph3P (reducing agent) is well 
established46 and is known as the Mitsunobu reaction47 when the reactant is an alcohol. The 
betaine (8) is the initially formed intermediate in all cases and it reacts with the alcohol. In the 
present case, this intermediate reacts as a nucleophile with the strongly electrophilic 
isoselenocyanate (1). 
 
Similar to the reaction with 6a, treatment of 4-bromophenyl isoselenocyanate (1b) with bis(tert-
butyl) azodicarboxylate (6b) and Ph3P gave the triazoloselone (7f) in almost quantitative yield. 
This product was transformed into the 3-tert-butoxy-4,5-dihydro-1H-1,2,4-triazole-5-selone (12) 
by decarboxylation with trifluoroacetic acid at room temperature in quantitative yield (Scheme 
4). 
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In conclusion, we have shown that aryl isoselenocyanates (1) under Mitsunobu conditions can 
be applied for the synthesis of 5-selenoxo-1,2,4-triazole derivatives in a one-pot procedure. 
 
EXPERIMENTAL 
 
General remarks. TLC: silica gel 60 F254 plates (0.25 mm, Merck). Column chromatography 
 (CC): silica gel 60 (0.040–0.063 mesh, Merck). Melting points: Büchi B-540 apparatus, in a 
capillary, uncorrected. IR spectra: Perkin-Elmer 1600-FT-IR spectrometer; in KBr, absorptions 
in cm-1. 1H-NMR (300 MHz) and 13C-NMR (75 MHz) spectra: Bruker ARX-300 instrument, in 
CDCl3; chemical shifts in ppm, coupling constants J in Hz. EI-MS: Finnigan SSQ-700 
instrument. 
 
Starting materials. Diethyl and bis(tert-butyl) azidodicarboxylate (6a and 6b) and 
triphenylphosphine (Ph3P) are commercially available (Fluka). Isoselenocyanates were 
prepared according to Barton’s procedure41 starting from the corresponding formamides. 
Formanilide was purchased (Fluka), N-(4-chlorophenyl)-, N-(4-bromophenyl)-, N-(4-
fluorophenyl)-, and N-(4-methylphenyl)formamide were prepared from the respective anilines 
and 95% formic acid. The solution was heated to reflux for 30 min and evaporated to dryness in 
vacuo. The residue was dissolved in ether (Et2O) and washed with diluted acetic acid (5%), 
water and aqueous NaHCO3 (5%). The aqueous layer was extracted with Et2O, the combined 
organic extracts were dried with MgSO4 and evaporated under reduced pressure. The crude 
products were purified by recrystallization in ethanol/water. 
 
Synthesis of 3-alkoxy-4,5-dihydro-5-selenoxo-1H-1,2,4-triazole-1-carboxylates (7a-d). 
General procedure. A 25 mL round-bottom flask equipped with magnetic stirrer and condenser 
was charged with a mixture of diethyl or bis(tert-butyl) azodicarboxylate (6a and 6b, 
respectively) (0.92 mL, 2.0 mmol) and Ph3P (524 mg, 2.0 mmol) in dichloromethane (20 mL). 
The mixture was stirred under an N2-atmosphere at 0°C (ice bath) for 30 min. An 
isoselenocyanate (1, 2.0 mmol) was added in one portion, the mixture was stirred for 15 h at rt, 
and evaporated to dryness under reduced pressure. The crude product was purified by column 
chromatography on SiO2 using hexane/ethyl acetate (AcOEt; 100/0 to 50/50) as eluant and 
recrystallization in AcOEt. 
 
Ethyl 3-ethoxy-4,5-dihydro-4-phenyl-5-selenoxo-1H-1,2,4-triazole-1-carboxylate (7a). Yield: 552 
mg (81%). Yellowish crystals; mp 142-144°C (AcOEt). IR: 3422w (br), 2981w, 2931w, 1773s, 
1619s, 1595w, 1501w, 1451m, 1386m, 1368m, 1328s, 1308s, 1220s, 1175w, 1155w, 1109w, 
1088w, 1066w, 1028m, 1005m, 979w, 902w, 861w, 847w, 776w, 710w, 689w. 1H-NMR: 1.36 (t, 
J = 7.1, CH3); 1.49 (t, J = 7.1, CH3); 4.49-4.62 (m, 2 CH2); 7.35 (d, J = 8.1, 2 arom. H); 7.52-
7.59 (m, 3 arom. H). 13C-NMR: 14.0 (CH3); 14.1 (CH3); 65.0 (CH2); 68.5 (CH2); 128.1 (2 arom. 
 CH); 129.4 (2 arom. CH); 130.0 (1 arom. CH); 132.6, 148.2 (1 arom. C, C(3)); 156.3 (C=Se); 
167.8 (C=O). ESI-MS: 360 (14), 361 (13), 362 (52), 363 (3), 364 (100, [M+Na]+), 365 (11), 366 
(15). Anal. Calcd for C13H15N3O3Se: C, 45.89; H, 4.44; N, 11.86. Found: C, 45.58; H, 4.58; N, 
12.64. 
 
Ethyl 4-(4-bromophenyl)-3-ethoxy-4,5-dihydro-5-selenoxo-1H-1,2,4-triazole-1-carboxylate (7b). 
Yield: 686 mg (82%). Yellowish crystals; mp 147-149°C (AcOEt). IR: 3444w (br), 2982w, 
2935w, 1755s, 1718m, 1638s, 1591w, 1493m, 1451m, 1392m, 1366m, 1327s, 1303s, 1286s, 
1215w, 1170w, 1154w, 1104w, 1068w, 1030m, 1011m, 988w, 909w, 850w, 754w, 711w. 1H-
NMR: 1.31 (t, J = 7.1, CH3); 1.41 (t, J = 7.1, CH3); 4.41-4.51 (m, 2 CH2); 7.20, 7.58 (AA’BB’, J ≈ 
8, 4 arom. H). 13C-NMR: 14.1 (CH3); 14.3 (CH3); 65.1 (CH2); 68.7 (CH2); 124.2 (1 arom. C); 
129.8 (2 arom. CH); 132.7 (2 arom. CH); 131.5, 148.9 (1 arom. C, C(3)); 155.6 (C=Se); 166.8 
(C=O). ESI-MS: 438 (15), 439 (12), 440 (55), 441 (4), 442 (100, [M+Na]+), 443 (14), 444 (12). 
Anal. Calcd for C13H14N3O3BrSe: C, 37.25; H, 3.37; N, 10.03. Found: C, 37.12; H, 3.23; N, 9.99. 
 
Ethyl 4-(4-chlorophenyl)-3-ethoxy-4,5-dihydro-5-selenoxo-1H-1,2,4-triazole-1-carboxylate (7c). 
Yield: 726 mg (97%). Yellowish crystals; mp 142-144°C (AcOEt). IR: 3442w (br), 2982w, 1765s, 
1625s, 1495m, 1469w, 1442w, 1373m, 1310s, 1289s, 1218s, 1173w, 1148w, 1089m, 1025m, 
977m, 907w, 836w, 753w, 703w. 1H-NMR: 1.31 (t, J = 7.1Hz, CH3); 1.41 (t, J = 7.1, CH3); 4.39-
4.51 (m, 2 CH2); 7.24, 7.43 (AA’BB’, J ≈ 8, 2H, 4 arom. H). 13C-NMR: 14.1 (CH3); 14.3 (CH3); 
65.1 (CH2); 68.7 (CH2); 124.6 1 arom. C); 129.5 (2 arom. CH); 129.7 (2 arom. CH); 131.0, 148.9 
(1 arom. C, C(3)); 155.6 (C=Se); 166.9 (C=O). ESI-MS: 394 (13), 395 (14), 396 (51), 397 (4), 
398 (100, [M+Na]+), 399 (18), 400 (49). Anal. Calcd for C13H14N3O3ClSe: C, 41.67; H, 3.77; N, 
11.21. Found: C, 41.63; H, 3.84; N, 11.34. 
 
Ethyl 3-ethoxy-4-(4-fluorophenyl)-4,5-dihydro-5-selenoxo-1H-1,2,4-triazole-1-carboxylate (7d). 
Yield: 603 mg (84%). Yellowish crystals; mp 151-153°C (AcOEt). IR: 3442w (br), 3085w, 
2982w, 1769s, 1621s, 1512s, 1475w, 1454m, 1386m, 1367m, 1311s, 1290s, 1216s, 1171w, 
1150w, 1112w, 1088w, 1063m, 1024m, 1004w, 977m, 905w, 853m, 821w, 759w, 725w, 711w, 
635w, 622m. 1H-NMR: 1.35 (t, J = 7.1, CH3); 1.49 (t, J = 7.1, CH3); 4.41-4.51 (m, 2 CH2); 6.95, 
7.19 (AA’BB’, J ≈ 8, 4 arom. H). 13C-NMR: 14.0 (CH3); 14.3 (CH3); 65.1 (CH2); 68.6 (CH2); 116.4 
(2 arom. CH, 2JC,F = 23); 130.1 (2 arom. CH); 128.4, 148.9 (1 arom. C, C(3)); 155.8 (C=Se); 
162.3 (CF, 1JC,F = 249); 167.1 (C=O). ESI-MS: 378 (15), 379 (12), 380 (55), 381 (4), 382 (100, 
 [M+Na]+), 383 (15), 384 (17). Anal. Calcd for C13H14N3O3FSe: C, 43.59; H, 3.94; N, 11.73. 
Found: 
C, 43.37; H, 4.00; N, 11.88. 
 
Ethyl 3-ethoxy-4,5-dihydro-4-(4-methylphenyl)-5-selenoxo-1H-1,2,4-triazole-1-carboxylate (7e). 
Yield: 554 mg (78%). Yellowish crystals; mp 120-122°C (AcOEt). IR: 3442w (br), 2979w, 
2956w, 1768s, 1619s, 1514m, 1477w, 1454m, 1389m, 1368m, 1327s, 1307s, 1294s, 1220s, 
1173w, 1152w, 1109w, 1099w, 1064w, 1029m, 981w, 905w, 850w, 817w, 753w, 712w, 622w. 
1H-NMR: 1.37 (t, J = 7.1, CH3); 1.49 (t, J = 7.1, CH3); 2.43 (s, CH3); 4.48-4.60 (m, 2 CH2); 7.22, 
7.34 (AA’BB’, J ≈ 8, 4 arom. H). 13C-NMR: 14.0 (CH3); 14.3 (CH3); 21.3 (CH3); 65.0 (CH2); 68.4 
(CH2); 127.7 (2 arom. CH); 130.0 (2 arom. CH); 127.3, 140.2 (1 arom. C, C(3)); 149.0 (1 arom. 
C); 156.0 (C=Se); 167.1 (C=O). ESI-MS: 374 (12), 375 (14), 376 (48), 377 (4), 378 (100, 
[M+Na]+), 379 (11), 380 (13), 733 (3). Anal. Calcd for C14H17N3O3Se: C, 47.46; H, 4.84; N, 
11.86. Found: C, 47.25; H, 4.85; N, 11.85. 
 
tert-Butyl 3-tert-butoxy-4-(4-bromophenyl)-4,5-dihydro-5-selenoxo-1H-1,2,4-triazole-1-
carboxylate (7f). Yield: 855 mg (90%). Yellowish crystals; mp 118-120°C (AcOEt). IR: 3443w 
(br), 2985w, 2931w, 1764s, 1701w, 1612s, 1488m, 1453w, 1408w, 1372m, 1337m, 1320s, 
1297m, 1278s, 1223m, 1143s, 1065w, 1000m, 895w, 848m, 836m, 804w, 761w, 655w. 1H-
NMR: 1.53 (s, 3 CH3); 1.67 (s, 3 CH3); 7.21, 7.62 (AA’BB’, J ≈ 8, 4 arom. H). 13C-NMR: 27.6 (3 
CH3); 27.8 (3 CH3); 86.6, 88.1 (2 C); 123.8 (1 arom. C); 129.8 (2 arom. CH); 132.5 (2 arom. 
CH); 132.1, 147.1 (1 arom. C, C(3)); 153.5 (C=Se); 165.1 (C=O). ESI-MS: 494 (17), 495 (15), 
496 (55), 497 (25), 498 (100, [M+Na]+), 499 (18), 500 (75), 501 (12), 502 (10). Anal. Calcd for 
C17H22N3O3BrSe: C, 42.96; H, 4.67; N, 8.83. Found: C, 43.22; H, 4.95; N, 9.15. 
 
Decarboxylation of 7f. 3-tert-Butoxy-4-(4-bromophenyl)-4,5-dihydro-1H-1,2,4-triazole-5-selone 
(12). Yield: 713 mg (95%). Yellowish crystals; mp 235-237°C (AcOEt). IR: 3329w (br), 3088w, 
2986w, 1612s, 1488m, 1410w, 1374m, 1343m, 1325s, 1298m, 1278s, 1222m, 1140s, 1078w, 
998m, 889w, 845m, 831m, 751w. 1H-NMR: 1.52 (s, 3 CH3); 4.36 (br s, NH); 7.19, 7.64 (AA’BB’, 
J ≈ 8, 4 arom. H). 13C-NMR: 31.6 (3 CH3); 86.5 (C); 121.5 (1 arom. C); 129.2 (2 arom. CH); 
131.7 (2 arom. CH); 132.1, 146.0 (1 arom. C, C(3)); 153.1 (C=Se). ESI-MS: 394 (16), 395 (14), 
396 (57), 397 (28), 398 (100, [M+Na]+), 399 (17), 400 (75), 401 (10), 402 (12). Anal. Calcd for 
C17H22N3O3BrSe: C, 38.42; H, 3.76; N, 11.20. Found: C, 38.54; H, 3.57; N, 11.56. 
  
X-Ray Crystal-Structure Determination of 7e (see Table 2 and Figure 1).48 All measurements 
were made on a Nonius KappaCCD area-detector diffractometer49 using graphite-
monochromated MoKα radiation (λ 0.71073 Å) and an Oxford Cryosystems Cryostream 700 
cooler. The data collection and refinement parameters are given in Table 1, and a view of the 
molecule is shown in Figure 1. Data reduction was performed with HKL Denzo and Scalepack.50 
The intensities were corrected for Lorentz and polarization effects, and an absorption correction 
based on the multi-scan method51 was applied. Equivalent reflections were merged. The 
structure was solved by direct methods using SHELXS97,52 which revealed the positions of all 
non-hydrogen atoms. The non-hydrogen atoms were refined anisotropically. All of the H-atoms 
were placed in geometrically calculated positions and refined using a riding model where each 
H-atom was assigned a fixed isotropic displacement parameter with a value equal to 1.2Ueq of 
its parent atom (1.5Ueq for the methyl groups). Refinement of the structure was carried out on  
F 2 using full-matrix least-squares procedures, which minimized the function Σw(Fo2– Fc2)
2
. A 
correction for secondary extinction was applied. Neutral atom scattering factors for non-
hydrogen atoms were taken from ref.,53 and the scattering factors for H-atoms were taken from 
ref.54 Anomalous dispersion effects were included in Fc;55 the values for f ' and f " were those of 
ref.56 The values of the mass attenuation coefficients are those of ref.57 All calculations were 
performed using the SHELXL9758 program. 
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